Subscribe
Subscribe
Home Tags Pharmaceutical Industry

Tag: Pharmaceutical Industry

$580 million EU antitrust fine for drug makers
Business

$580 million EU antitrust fine for drug makers

Washington Examiner -
0
It's no surprise the manufacturers and sellers of sterilization and contraception have lobbied on the Obama administration's contraception mandate, backed the Obamacare law Obama uses to justify the mandate, and fought for Obama's election and re-election. (iStock Photo)
Beltway Confidential

The drug lobby vs. Hobby Lobby: Pharma lobbyists and the contraception mandate

Timothy P. Carney -
0
(Thinkstock)
Columnists

Who should have say on a patient taking experimental drugs?

Walter Williams -
0
City of Chicago sues over painkiller marketing

City of Chicago sues over painkiller marketing

Carla Johnson -
0
Drug makers are under fire as the $84,000 price tag on a new hepatitis medicine has galvanized the debate over prescription drug costs. But the pharmaceutical industry could be mounting a much stronger defense if it weren't haunted by its support for government health care. (Thinkstock Image)
Columnists

Pharmaceutical industry haunted by support for government health care

Philip Klein -
0
In this May 4, 2014 photo, the Pfizer logo is displayed on the exterior of a former Pfizer factory in the Brooklyn borough of New York. Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca. The Monday, May 26, 2014 announcement comes a week after AstraZeneca's board rejected a proposed $119 billion buyout offer from Pfizer, the world's second-biggest drugmaker by revenue. (AP Photo/Mark Lennihan, File)
Business

Pfizer pulls plug on push to buy AstraZeneca

Alex Veiga -
0
FDA approves new antibiotic for skin infections
Business

FDA approves new antibiotic for skin infections

Washington Examiner -
0
FILE - This Friday May 2, 2014 file photo shows an exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London. The board of AstraZeneca has rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, Monday May 19, 2014, a decision that has caused a sharp slide in the U.K. company's share price as investors think it effectively brings an end to the protracted and increasingly bitter takeover saga. (AP Photo/Matt Dunham, File)
Business

AstraZeneca rejects $119 billion offer from Pfizer

Washington Examiner -
0
CEO of China drug maker jumps to death amid probe
Business

CEO of China drug maker jumps to death amid probe

Washington Examiner -
0
Pfizer raises offer, highlighting flurry of deals
Business

Pfizer raises offer, highlighting flurry of deals

The Associated Press -
0
1...145146147...154Page 146 of 154
Do Not Sell or Share My Personal Information

NEWS

POLICY

COMMENTARY

RESTORING AMERICA